Giovacchini G, Giovannini E, Riondato M, Ciarmiello A1.
Curr Radiopharm. 2016 Dec 29. [Epub ahead of print]Neuroendocrine differentiation of prostate cancer (PCa) is a relatively frequent event, generally understudied, that carries important prognostic information. It is most frequently observed during the advanced stages of disease, when PCa has lost its sensitivity to androgen deprivation therapy or to chemotherapy, moderate to diffuse bone metastatic spread dominates the imaging scenario and it is responsible for painful clinical symptomatology. Read More